Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
29
CRMT Quote, Financials, Valuation and Earnings
Last price:
$25.26
Seasonality move
:
4.91%
Day range:
$25.01 - $26.61
52-week range:
$17.78 - $62.72
Dividend yield:
0%
P/E ratio:
16.64x
P/S ratio:
0.15x
P/B ratio:
0.38x
Volume:
172K
Avg. volume:
203.4K
1-year change:
-50.71%
Market cap:
$209.5M
Revenue:
$1.4B
EPS (TTM):
-$1.77
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Revenue | $909.7M | $1.2B | $1.4B | $1.4B | $1.4B | |
| Revenue Growth (YoY) | 22.17% | 30.15% | 17.14% | -0.47% | -0.21% | |
| Cost of Revenues | $479.2M | $667.7M | $806.4M | $765.4M | $733.7M | |
| Gross Profit | $430.5M | $527.9M | $594M | $628.5M | $657.2M | |
| Gross Profit Margin | 47.33% | 44.15% | 42.42% | 45.09% | 47.25% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $130.9M | $156.1M | $176.7M | $179.4M | $188.9M | |
| Other Inc / (Exp) | $40K | -$149K | -$361K | -$437K | -$299K | |
| Operating Expenses | $288.4M | $394.2M | $529.6M | $602.8M | $563.5M | |
| Operating Income | $142.1M | $133.7M | $64.5M | $25.7M | $93.8M | |
| Net Interest Expenses | $6.8M | $10.9M | $38.3M | $65.3M | $70.7M | |
| EBT. Incl. Unusual Items | $135.3M | $122.6M | $25.8M | -$40.1M | $22.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $30.5M | $27.6M | $5.4M | -$8.7M | $4.9M | |
| Net Income to Company | $104.8M | $95M | $20.4M | -$31.4M | $17.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $104.8M | $95M | $20.4M | -$31.4M | $17.9M | |
| Basic EPS (Cont. Ops) | $15.81 | $14.60 | $3.20 | -$4.92 | $2.38 | |
| Diluted EPS (Cont. Ops) | $15.05 | $13.92 | $3.11 | -$4.92 | $2.33 | |
| Weighted Average Basic Share | $6.6M | $6.5M | $6.4M | $6.4M | $7.5M | |
| Weighted Average Diluted Share | $7M | $6.8M | $6.6M | $6.4M | $7.7M | |
| EBITDA | $145.9M | $137.7M | $70.1M | $32.5M | $101.4M | |
| EBIT | $142.2M | $133.7M | $64.5M | $25.7M | $93.8M | |
| Revenue (Reported) | $909.7M | $1.2B | $1.4B | $1.4B | $1.4B | |
| Operating Income (Reported) | $142.1M | $133.7M | $64.5M | $25.7M | $93.8M | |
| Operating Income (Adjusted) | $142.2M | $133.7M | $64.5M | $25.7M | $93.8M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $284.5M | $351.8M | $359.8M | $347.3M | $350.2M | |
| Revenue Growth (YoY) | 27.39% | 23.65% | 2.26% | -3.48% | 0.84% | |
| Cost of Revenues | $158.1M | $207.5M | $198.5M | $175.1M | $181.1M | |
| Gross Profit | $126.4M | $144.4M | $161.3M | $172.1M | $169.1M | |
| Gross Profit Margin | 44.43% | 41.04% | 44.84% | 49.57% | 48.28% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $37.2M | $42.9M | $44.9M | $47.4M | $57.2M | |
| Other Inc / (Exp) | -$44K | -$242K | -$74K | -$41K | -- | |
| Operating Expenses | $93.7M | $131.7M | $180.3M | $146.9M | $176.3M | |
| Operating Income | $32.8M | $12.7M | -$18.9M | $25.2M | -$7.2M | |
| Net Interest Expenses | $2.5M | $8.4M | $16.6M | $18M | $15.7M | |
| EBT. Incl. Unusual Items | $30.2M | $4.1M | -$35.6M | $7.1M | -$27.5M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.8M | $919K | -$8.1M | $2M | -$5M | |
| Net Income to Company | $24.5M | $3.1M | -$27.5M | $5.1M | -$22.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $23.4M | $3.1M | -$27.5M | $5.1M | -$22.5M | |
| Basic EPS (Cont. Ops) | $3.59 | $0.49 | -$4.30 | $0.62 | -$2.71 | |
| Diluted EPS (Cont. Ops) | $3.41 | $0.48 | -$4.30 | $0.61 | -$2.71 | |
| Weighted Average Basic Share | $6.5M | $6.4M | $6.4M | $8.1M | $8.3M | |
| Weighted Average Diluted Share | $6.9M | $6.5M | $6.4M | $8.3M | $8.3M | |
| EBITDA | $33.7M | $14M | -$17.2M | $27.1M | -$5.1M | |
| EBIT | $32.8M | $12.7M | -$18.9M | $25.2M | -$7.2M | |
| Revenue (Reported) | $284.5M | $351.8M | $359.8M | $347.3M | $350.2M | |
| Operating Income (Reported) | $32.8M | $12.7M | -$18.9M | $25.2M | -$7.2M | |
| Operating Income (Adjusted) | $32.8M | $12.7M | -$18.9M | $25.2M | -$7.2M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $581.2M | $757.6M | $810M | $723.2M | $728.4M | |
| Gross Profit | $491M | $572.2M | $628.9M | $636.1M | $659M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $145.5M | $166.3M | $181.9M | $182.2M | $203.4M | |
| Other Inc / (Exp) | -$70K | -$353K | -$349K | -$284K | -- | |
| Operating Expenses | $339.8M | $468.3M | $601.4M | $568.8M | $605.2M | |
| Operating Income | $151.1M | $103.9M | $27.5M | $67.3M | $53.8M | |
| Net Interest Expenses | $7.9M | $22.1M | $53.5M | $70.8M | $67M | |
| EBT. Incl. Unusual Items | $143.1M | $81.4M | -$26.4M | -$3.8M | -$18M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $31.3M | $18.8M | -$6.7M | $150K | -$3.6M | |
| Net Income to Company | $112.9M | $62.4M | -$19.7M | -$4M | -$14.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $111.8M | $62.7M | -$19.7M | -$4M | -$14.4M | |
| Basic EPS (Cont. Ops) | $16.93 | $9.75 | -$3.09 | -$0.80 | -$1.74 | |
| Diluted EPS (Cont. Ops) | $16.02 | $9.38 | -$3.13 | -$0.81 | -$1.77 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $154.8M | $108.5M | $34M | $74.6M | $61.9M | |
| EBIT | $151.1M | $103.9M | $27.5M | $67.3M | $53.8M | |
| Revenue (Reported) | $1.1B | $1.3B | $1.4B | $1.4B | $1.4B | |
| Operating Income (Reported) | $151.1M | $103.9M | $27.5M | $67.3M | $53.8M | |
| Operating Income (Adjusted) | $151.1M | $103.9M | $27.5M | $67.3M | $53.8M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | $564.9M | $690.7M | $726.6M | $695M | $691.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $310.9M | $401.7M | $402.8M | $363.6M | $358.3M | |
| Gross Profit | $254M | $288.9M | $323.8M | $331.4M | $333.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $76M | $86.1M | $91.3M | $94.1M | $108.6M | |
| Other Inc / (Exp) | -$46K | -$250K | -$240K | -$87K | -- | |
| Operating Expenses | $187.5M | $251.2M | $323.1M | $289.1M | $330.7M | |
| Operating Income | $66.5M | $37.7M | $725K | $42.4M | $2.4M | |
| Net Interest Expenses | $4.5M | $15.7M | $30.9M | $36.4M | $32.7M | |
| EBT. Incl. Unusual Items | $62M | $21.8M | -$30.4M | $5.9M | -$34.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $13.6M | $4.9M | -$7.1M | $1.8M | -$6.7M | |
| Net Income to Company | $49.5M | $16.8M | -$23.3M | $4.1M | -$28.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $48.4M | $16.8M | -$23.3M | $4.1M | -$28.2M | |
| Basic EPS (Cont. Ops) | $7.37 | $2.64 | -$3.65 | $0.47 | -$3.41 | |
| Diluted EPS (Cont. Ops) | $6.98 | $2.55 | -$3.67 | $0.46 | -$3.41 | |
| Weighted Average Basic Share | $13.1M | $12.7M | $12.8M | $14.5M | $16.6M | |
| Weighted Average Diluted Share | $13.9M | $13.1M | $13M | $14.7M | $16.6M | |
| EBITDA | $68.4M | $40.2M | $4.1M | $46.2M | $6.7M | |
| EBIT | $66.5M | $37.7M | $725K | $42.4M | $2.4M | |
| Revenue (Reported) | $564.9M | $690.7M | $726.6M | $695M | $691.5M | |
| Operating Income (Reported) | $66.5M | $37.7M | $725K | $42.4M | $2.4M | |
| Operating Income (Adjusted) | $66.5M | $37.7M | $725K | $42.4M | $2.4M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.9M | $42.6M | $68M | $94.4M | $124.5M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $625.1M | $863.7M | $1.1B | $1.1B | $1.2B | |
| Inventory | $82.3M | $115.3M | $109.3M | $107.5M | $112.2M | |
| Prepaid Expenses | $6.1M | -- | -- | -- | -- | |
| Other Current Assets | -- | $15.1M | -- | -- | -- | |
| Total Current Assets | $719.8M | $1B | $1.3B | $1.3B | $1.4B | |
| Property Plant And Equipment | $95.1M | $104.2M | $120.8M | $121.5M | $120.7M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $7.3M | $8.6M | $11.7M | $14.4M | $22.8M | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $26M | $31.3M | $38.1M | |
| Total Assets | $822.2M | $1.2B | $1.4B | $1.5B | $1.7B | |
| Accounts Payable | $18.2M | $20.1M | $27.2M | $21.4M | $35M | |
| Accrued Expenses | $5.2M | $7.6M | $8.2M | $10M | $16.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $82.1M | $152.7M | $175.6M | $170M | $195.7M | |
| Long-Term Debt | $225.9M | $494.6M | $700.9M | $818.7M | $833.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $415.3M | $686.6M | $927.5M | $1B | $1.1B | |
| Common Stock | $536K | $136K | $137K | $137K | $156K | |
| Other Common Equity Adj | -$257.5M | -$292.2M | -- | -- | -- | |
| Common Equity | $406.4M | $476.4M | $498.4M | $470.7M | $569.4M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $100K | $100K | $100K | $100K | $100K | |
| Total Equity | $406.9M | $476.9M | $498.9M | $471.2M | $569.9M | |
| Total Liabilities and Equity | $822.2M | $1.2B | $1.4B | $1.5B | $1.7B | |
| Cash and Short Terms | $2.9M | $42.6M | $68M | $94.4M | $124.5M | |
| Total Debt | $227.7M | $494.6M | $700.9M | $818.7M | $833.7M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $2.1M | $37.1M | $94.5M | $129.7M | $251M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $748.2M | $986.9M | $1.1B | $1.1B | $1.2B | |
| Inventory | $109M | $130.3M | $113.8M | $122.1M | $104.8M | |
| Prepaid Expenses | $7.9M | $9.5M | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $871.6M | $1.2B | $1.4B | $1.4B | $1.6B | |
| Property Plant And Equipment | $97.7M | $123.8M | $120.7M | $125.1M | $114M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $7.5M | $8.8M | $11.6M | $22.9M | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | $30.5M | $35.3M | -- | |
| Total Assets | $976.9M | $1.3B | $1.5B | $1.6B | $1.7B | |
| Accounts Payable | $21.7M | $24.8M | $22.4M | $34.2M | $45.5M | |
| Accrued Expenses | $6.4M | $7.6M | $9.5M | $17.7M | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $133.4M | $168.4M | $180.8M | $181.1M | $197M | |
| Long-Term Debt | $381.2M | $609.5M | $804.2M | $827.7M | $957.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $539M | $813.5M | $1B | $1B | $1.2B | |
| Common Stock | $136K | $137K | $137K | $156K | $156K | |
| Other Common Equity Adj | -$277.5M | -$297.4M | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $100K | $100K | $100K | $100K | $100K | |
| Total Equity | $437.9M | $492.7M | $477M | $554.1M | $555.5M | |
| Total Liabilities and Equity | $976.9M | $1.3B | $1.5B | $1.6B | $1.7B | |
| Cash and Short Terms | $2.1M | $37.1M | $94.5M | $129.7M | $251M | |
| Total Debt | $385.8M | $609.5M | $804.2M | $827.7M | $957.7M | |
| Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $104.8M | $95M | $20.4M | -$31.4M | $17.9M | |
| Depreciation & Amoritzation | $3.7M | $4M | $5.6M | $6.9M | $7.6M | |
| Stock-Based Compensation | $6M | $5.5M | $5.3M | $4.2M | $4.7M | |
| Change in Accounts Receivable | -$392.7M | -$593.6M | -$727.9M | -$624.9M | -$606.2M | |
| Change in Inventories | $5M | $51.1M | $133M | $139.2M | $114.6M | |
| Cash From Operations | -$53.8M | -$119.2M | -$135.7M | -$73.9M | -$48.8M | |
| Capital Expenditures | $9M | $15.8M | $22.1M | $6.1M | $3.9M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$8.3M | -$17.4M | -$27.6M | -$10.6M | -$11.4M | |
| Dividends Paid (Ex Special Dividend) | -$40K | $40K | $40K | $40K | $40K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $73.3M | $731.1M | $924.7M | $1.2B | $1.3B | |
| Long-Term Debt Repaid | -$63.1M | -$511M | -$730M | -$1B | -$1.2B | |
| Repurchase of Common Stock | -$10.6M | $34.7M | $5.2M | $365K | $434K | |
| Other Financing Activities | -$282K | -$6.1M | -$2.3M | -$5.9M | -$9M | |
| Cash From Financing | $5.4M | $176.2M | $188.7M | $111M | $90.2M | |
| Beginning Cash (CF) | $59.6M | $42.6M | $68M | $94.4M | $124.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$56.7M | $39.7M | $25.4M | $26.4M | $30.1M | |
| Ending Cash (CF) | $2.9M | $82.3M | $93.5M | $120.9M | $154.6M | |
| Levered Free Cash Flow | -$62.8M | -$135M | -$157.8M | -$80M | -$52.7M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $24.5M | $3.1M | -$27.5M | $5.1M | -$22.5M | |
| Depreciation & Amoritzation | $958K | $1.3M | $1.7M | $1.9M | $2.1M | |
| Stock-Based Compensation | $977K | $820K | -$712K | $3.9M | $1.2M | |
| Change in Accounts Receivable | -$145.3M | -$191.3M | -$174M | -$143.5M | -$147.5M | |
| Change in Inventories | $6.5M | $46.7M | $41.2M | $22.5M | $39.9M | |
| Cash From Operations | -$38.6M | -$32.3M | -$30.7M | -$22.2M | $9.1M | |
| Capital Expenditures | $5.2M | $9.5M | $770K | $1.4M | $784K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$5.4M | -$9.7M | -$738K | -$1.3M | -$687K | |
| Dividends Paid (Ex Special Dividend) | $10K | $10K | $10K | $10K | $10K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $88.8M | $121.7M | $172.9M | $461.5M | -- | |
| Long-Term Debt Repaid | -$35.4M | -$84.5M | -$139.2M | -$477.3M | -- | |
| Repurchase of Common Stock | $8.3M | -- | -- | $388K | $205K | |
| Other Financing Activities | -$1.8M | $50K | -- | -$3.1M | -- | |
| Cash From Financing | $43.3M | $37.2M | $33.8M | $54.6M | $121.2M | |
| Beginning Cash (CF) | $2.1M | $37.1M | $94.5M | $129.7M | $251M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$595K | -$4.8M | $2.3M | $31.1M | $129.5M | |
| Ending Cash (CF) | $1.5M | $32.3M | $96.8M | $160.7M | $380.5M | |
| Levered Free Cash Flow | -$43.7M | -$41.8M | -$31.5M | -$23.6M | $8.3M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $112.9M | $62.4M | -$19.7M | -$4M | -$14.4M | |
| Depreciation & Amoritzation | $3.7M | $4.6M | $6.5M | $7.3M | $8.1M | |
| Stock-Based Compensation | $6.2M | $4.3M | $4.3M | $7.7M | $1.8M | |
| Change in Accounts Receivable | -$511.3M | -$685.5M | -$716M | -$565.3M | -$595M | |
| Change in Inventories | $20.8M | $90.1M | $151.9M | $122.2M | $135M | |
| Cash From Operations | -$94M | -$141.9M | -$119.2M | -$35M | -$8.4M | |
| Capital Expenditures | $10.8M | $25.4M | $7.8M | $6.3M | $2.8M | |
| Cash Acquisitions | -- | -- | -- | $7.5M | -$7.5M | |
| Cash From Investing | -$10.9M | -$26.9M | -$12.5M | -$18.9M | -$2.7M | |
| Dividends Paid (Ex Special Dividend) | $40K | $40K | $40K | $40K | $40K | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $234.9M | $837.1M | $1.3B | $1.3B | -- | |
| Long-Term Debt Repaid | -$123.5M | -$608.2M | -$1.1B | -$1.3B | -- | |
| Repurchase of Common Stock | $24.5M | $19.9M | $68K | $709K | $298K | |
| Other Financing Activities | -- | -$4.4M | -$6.3M | -$6.3M | -- | |
| Cash From Financing | $87.5M | $203.8M | $189.1M | $89.1M | $132.4M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$17.4M | $35M | $57.4M | $35.2M | $121.3M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$104.8M | -$167.3M | -$127M | -$41.3M | -$11.2M | |
| Period Ending | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2025-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $49.5M | $16.8M | -$23.3M | $4.1M | -$28.2M | |
| Depreciation & Amoritzation | $1.9M | $2.5M | $3.4M | $3.8M | $4.2M | |
| Stock-Based Compensation | $3.9M | $2.8M | $1.7M | $5.2M | $2.3M | |
| Change in Accounts Receivable | -$283.1M | -$374.9M | -$363.1M | -$303.5M | -$292.2M | |
| Change in Inventories | $7.2M | $46.2M | $65.1M | $48.1M | $68.5M | |
| Cash From Operations | -$70M | -$92.7M | -$76.1M | -$37.2M | $3.1M | |
| Capital Expenditures | $6.8M | $16.5M | $2.1M | $2.3M | $1.2M | |
| Cash Acquisitions | -- | -- | -- | $7.5M | -- | |
| Cash From Investing | -$7.1M | -$16.7M | -$1.6M | -$9.8M | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | $20K | $20K | $20K | $20K | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $165.2M | $271.2M | $638M | $748.4M | -- | |
| Long-Term Debt Repaid | -$66.3M | -$163.4M | -$529.4M | -$735.2M | -- | |
| Repurchase of Common Stock | -$3.3M | $5.2M | $68K | $412K | $276K | |
| Other Financing Activities | -$1.8M | -$39K | -$4.1M | -$4.5M | -- | |
| Cash From Financing | $76.3M | $103.9M | $104.2M | $82.3M | $124.4M | |
| Beginning Cash (CF) | $5M | $79M | $186.7M | $228.3M | $372.4M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$769K | -$5.5M | $26.5M | $35.2M | $126.4M | |
| Ending Cash (CF) | $4.2M | $73.5M | $213.2M | $263.5M | $498.8M | |
| Levered Free Cash Flow | -$76.8M | -$109.1M | -$78.3M | -$39.5M | $1.9M | |
Get CRMT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRMT
Sector
P/E ratio
16.64x
17.14x
PEG ratio
-0.12x
0.11x
P/B ratio
0.38x
1.34x
Price / LTM sales
0.15x
0.57x
Growth Metrics
CRMT
Sector
Revenue growth
0.84%
3.46%
Earnings growth
-542.27%
--
Revenue (5-year growth)
13.31%
3.16%
Earnings forecast
-$0.28
$0.26
Profitability
CRMT
Sector
Profitability FY 2025
$657.2M
$298.2M
Return on invested capital
-1.01%
3.41%
Return on assets
-0.88%
2.25%
Return on equity
-2.57%
5.88%
Earnings Date
Last Earnings Date
Dec
4
Next Earnings Date
Mar
5
Estimated Next Earnings Date
Mar
5
Balance Sheet
CRMT
Sector
Total cash
$251M
$130M
Short term investments
--
$41M
Total assets
$1.7B
$1.1B
Long term debt
$957.7M
$34.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
Buy
75
AXSM alert for Jan 1
Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.
Sell
50
NUTX alert for Jan 1
Nutex Health, Inc. [NUTX] is down 9.81% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
